DUBLIN–(BUSINESS WIRE)–The “Global Injectable Drug Delivery Devices Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.
The injectable drug delivery devices market is poised to grow by $22.29 bn during 2022-2026, progressing at a CAGR of 8.48% during the forecast period. The report on the injectable drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases and growth in the biologics market.
The injectable drug delivery devices market analysis includes the type segment and geographic landscape.
The injectable drug delivery devices market is segmented as below:
By Type
- Advanced injectable drug delivery devices
- Conventional injectable drug delivery devices
By Geography
- North America
- Europe
- Asia
- ROW
This study identifies digitalization in the healthcare system as one of the prime reasons driving the injectable drug delivery devices market growth during the next few years.
The report on injectable drug delivery devices market covers the following areas:
- Injectable drug delivery devices market sizing
- Injectable drug delivery devices market forecast
- Injectable drug delivery devices market industry analysis
Key Topics Covered:
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Type
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
Companies Mentioned
- AstraZeneca Plc
- Baxter International Inc.
- Becton Dickinson and Co.
- Eli Lilly and Co.
- Gerresheimer AG
- Owen Mumford Ltd.
- Sanofi SA
- SCHOTT AG
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
For more information about this report visit https://www.researchandmarkets.com/r/relxr2
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900